Results 181 to 190 of about 14,337,199 (401)
Abstract Aims This study aimed to evaluate the change of the main electrocardiographic (ECG) characteristics and their prognostic role across the main subtypes of cardiac amyloidosis [light‐chain amyloidosis (AL) and hereditary (ATTRv) and wild‐type transthyretin amyloidosis (ATTRwt)].
Alessia Argirò+20 more
wiley +1 more source
E. coli expression and characterization of a mutant troponin I with the three cysteine residues substituted [PDF]
Lan Kluwe, Kayo Maéda, Yuichiro Maéda
openalex +1 more source
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya+9 more
wiley +1 more source
Production and Characterisation of Anti‐Cardiac Troponin‐I Monoclonal Antibodies [PDF]
Kh. H. Haider, W.H. Stimson
openalex +1 more source
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba+10 more
wiley +1 more source
Fast and slow isoforms of troponin I and troponin C [PDF]
Karl‐Thomas HÄRTNER, Dirk Pette
openalex +1 more source
Comparative molecular modeling of Amphioxus calcium vector protein with calmodulin and troponin C [PDF]
Jos A. Cox+2 more
openalex +1 more source
Degradation of cardiac troponin I: implication for reliable immunodetection [PDF]
A. Katrukha+12 more
openalex +1 more source
Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo+7 more
wiley +1 more source